Source: FinanzNachrichten

Kuros Biosciences AG: EQS-Adhoc: Kuros Biosciences AG: Kuros Biosciences's MagnetOs Flex Matrix Cleared by FDA for Spinal Indications

Kuros Biosciences AG / Key word(s): Miscellaneous Kuros Biosciences's MagnetOs Flex Matrix Cleared by FDA for Spinal Indications 21-Apr-2022 / 07:00 CET/CEST Release of an ad hoc announcement purs...

Read full article »
Est. Annual Revenue
$100K-5.0M
Est. Employees
25-100
Joost De Bruijn's photo - CEO of Kuros Biosciences AG

CEO

Joost De Bruijn

CEO Approval Rating

90/100

Read more